January 29, 2025

FDA Approves Acalabrutinib With Bendamustine and Rituximab for Previously Untreated Mantle Cell Lymphoma

On January 16, the U.S. Food and Drug Administration (FDA) granted traditional approval to acalabrutinib (Calquence) with bendamustine and rituximab for adults with previously untreated mantle cell ly...

The ASCO Post

January 28, 2025

T-DXd Approved by the FDA for Pretreated Patients With HER2-Low or -Ultralow Metastatic Breast Cancer

The antibody-drug conjugate fam-trastuzumab deruxtecan-nxki (T-DXd) has been approved for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-low or HE...

The ASCO Post

January 07, 2025

Addition of Palbociclib to Standard Therapy in Metastatic Hormone Receptor–Positive, HER2-Positive Breast Cancer

Addition of the CDK4/6 inhibitor palbociclib to the current standard of care for first-line maintenance therapy after induction chemotherapy achieved statistically significant and clinically meaningfu...

The ASCO Post

January 06, 2025

Risk-Reducing Surgeries Improve Survival for Younger Patients With Breast Cancer Who Are BRCA Carriers, Study Finds

Patients with early-onset breast cancer (aged 40 or younger at diagnosis) who have BRCA1 and/or BRCA2 pathogenic or likely pathogenic variants had improved overall survival by undergoing risk-reducing...

The ASCO Post

July 01, 2023

GA THERAPIES ON THE WAY

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Ophthalmology Management

July 06, 2023

Faculty Publications: June 29-July 6

This week’s edition of Faculty Publications includes Cedars-Sinai studies that were published June 29-July 6.

Cedars-Sinai Pulse

May 09, 2023

Fibula free flap (free tissue transfer) for mandibular reconstruction

Mayo Clinic otolaryngologist Eric J. Moore, M.D. demonstrates a fibular free flap reconstruction of a mandibular defect following an oncologic resection for oral cavity cancer.

Mayo Clinic

December 06, 2023

'Game-Changer’ Intervention for Ovarian Cancer Prevention

Gynecologic oncologist Rebecca Stone and colleagues at Johns Hopkins are leading the way in salpingectomy — a quick, low-risk surgical intervention that can significantly reduce the risk of ovarian cancer.

Johns Hopkins Medicine

March 29, 2023

TTUHSC El Paso Hunt School of Dental Medicine Receives $10,000 Gift from Trellis Company

TTUHSC El Paso Receives $10K from Trellis

Inside Dentistry